Protalix BioTherapeutics, Inc. logo

Protalix BioTherapeutics, Inc.

AMEX:PLX

Overview | Financials
Company Name Protalix BioTherapeutics, Inc.
Symbol PLX
Currency USD
Price 1.4
Market Cap 100,213,120
Dividend Yield 0%
52-week-range 1.03 - 3.55
Industry Biotechnology
Sector Healthcare
CEO Mr. Dror Bashan
Website https://www.protalix.com

An error occurred while fetching data.

About Protalix BioTherapeutics, Inc.

Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso for the treatment of Gaucher disease. Its product

Related Stocks

Xtant Medical Holdings, Inc. logo

Xtant Medical Holdings, Inc.

XTNT

1.15 USD

AIM ImmunoTech Inc. logo

AIM ImmunoTech Inc.

AIM

0.449 USD

Milestone Scientific Inc. logo

Milestone Scientific Inc.

MLSS

0.804 USD

Financials

Numbers are in millions USD

Numbers are in millions USD